GURUFOCUS.COM » STOCK LIST » Technology » Software » Cellgentek Co Ltd (XKRX:258250) » Definitions » Interest Expense

Cellgentek Co (XKRX:258250) Interest Expense : ₩-1,602 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Cellgentek Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cellgentek Co's interest expense for the six months ended in Dec. 2023 was ₩ -1,602 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,602 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cellgentek Co's Operating Income for the six months ended in Dec. 2023 was ₩ -3,315 Mil. Cellgentek Co's Interest Expense for the six months ended in Dec. 2023 was ₩ -1,602 Mil. Cellgentek Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Cellgentek Co Interest Expense Historical Data

The historical data trend for Cellgentek Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellgentek Co Interest Expense Chart

Cellgentek Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
-860.26 -1,115.56 -1,139.48 -1,484.50 -1,602.27

Cellgentek Co Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense -860.26 -1,115.56 -1,139.48 -1,484.50 -1,602.27

Cellgentek Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,602 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellgentek Co  (XKRX:258250) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cellgentek Co's Interest Expense for the six months ended in Dec. 2023 was ₩-1,602 Mil. Its Operating Income for the six months ended in Dec. 2023 was ₩-3,315 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was ₩6,432 Mil.

Cellgentek Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Cellgentek Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Cellgentek Co Business Description

Traded in Other Exchanges
N/A
Address
579-4 Yuseong-daero, Yuseong-gu, Daejeon, KOR
Cellgentek Co Ltd is engaged in provision of information technology services for IT venture companies including computer, IT software development and franchise business. It is also engaged in development of drugs.

Cellgentek Co Headlines

No Headlines